Evidence map›Paper›PMID 28210682›Full record

ArticleCellular and molecular gastroenterology and hepatology2015

Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells.

Pascal Lapierre, Valérie Janelle, Marie-Pierre Langlois, Esther Tarrab, Tania Charpentier, Alain Lamarre

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Immunopathogenesis of Hepatitis C Virus Infection.Gastroenterology clinics of North America · 2015
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pascal LapierreImmunovirology laboratory, Institut national de la recherche scientifique, INRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Valérie JanelleImmunovirology laboratory, Institut national de la recherche scientifique, INRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Marie-Pierre LangloisImmunovirology laboratory, Institut national de la recherche scientifique, INRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Esther TarrabImmunovirology laboratory, Institut national de la recherche scientifique, INRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Tania CharpentierImmunovirology laboratory, Institut national de la recherche scientifique, INRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Alain LamarreImmunovirology laboratory, Institut national de la recherche scientifique, INRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Institut National de la Recherche Scientifique · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsThe constant exposure of the liver to food and bacterial antigens through the mesenteric circulation requires it to maintain tolerance while preserving the ability to mount an effective immune response against pathogens. We investigated the contribution of the liver's tolerogenic nature on the establishment of chronic viral infections.

methodsTTR-NP mice, which express the nucleoprotein (NP) of lymphocytic choriomeningitis virus (LCMV) specifically in hepatocytes under control of a modified transthyretin (TTR) promoter, were infected with the Armstrong (Arm) or WE acute strains of LCMV.

resultsThe infection persisted for at least 147 days in TTR-NP mice. Expression of NP by the liver induced a strong peripheral tolerance against NP that was mediated by interleukin-10-secreting CD4

conclusionsExpression of a viral antigen by hepatocytes can induce a state of peripheral tolerance mediated by regulatory T cells that can lead to the establishment of a chronic viral infection. Strategies targeting regulatory T cells in patients chronically infected with hepatotropic viruses could represent a promising approach to restore functional antiviral immunity and clear infection.

Indexed as

ALT, alanine aminotransferaseAPC, allophycocyaninArm, Armstrong strainBTLA, B and T lymphocyte attenuatorCFSE, carboxyfluorescein diacetate succinimidyl esterChronic InfectionCTL, cytotoxic T lymphocyteELISA, enzyme-linked immunoassayFACS, fluorescence-activated cell sorterFoxP3, forkhead box P3GP, glycoproteinHBV, hepatitis B virusHCV, hepatitis C virusHepatitisIFN, interferonIL, interleukinIP, intraperitonealIV, intravenousLCMV, lymphocytic choriomeningitis virusLIL, liver-infiltrating lymphocytesNP, nucleoproteinP14, GP33–41-specific TCR transgenicPD-1, programmed death-1PD-L1, programmed death-ligand-1PE, phycoerythrinpfu, plaque-forming unitsRAG, recombination-activating geneTCR, T-cell receptorTNF-α, tumor necrosis factor-αTNP4, NP396–404-specific TCR transgenicToleranceTreg, regulatory T cellTTR, transthyretin

Identifiers

PMID28210682
PMCPMC5301191
OpenAlexW2021087580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.